AMBIC was recently funded effective September 1, 2016.

We envision a future where society can harness biological knowledge to efficiently, effectively, reliably, and predictably manufacture protein-based medicines.

Our mission is to develop enabling technologies, knowledge, and design tools and methods that apply and integrate high-throughput and genome-based technologies to fast-track advanced biomanufacturing focused primarily on upstream issues. We are also committed to enlarging the cadre of scientists and engineers capable of advancing biomanufacturing technologies.

Save the date: AMBIC's Launch meeting will be held during the week of December 5-9, 2016. Details to follow.

If you have any questions, please contact us.